首页> 美国卫生研究院文献>Scientific Reports >Co-regulatory Network of Oncosuppressor miRNAs and Transcription Factors for Pathology of Human Hepatic Cancer Stem Cells (HCSC)
【2h】

Co-regulatory Network of Oncosuppressor miRNAs and Transcription Factors for Pathology of Human Hepatic Cancer Stem Cells (HCSC)

机译:抑癌基因miRNA和转录因子对人类肝癌干细胞(HCSC)病理的共同调控网络

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hepatic cancer stem cells (HCSCs) are considered as main players for the hepatocellular carcinoma (HCC) initiation, metastasis, drug resistance and recurrence. There is a growing evidence supporting the down-regulated miRNAs in HCSCs as key suppressors for the stemness traits, but still more details are vague about how these miRNAs modulate the HCC development. To uncover some of these miRNA regulatory aspects in HCSC, we compiled 15 down-regulated miRNA and their validated and predicted up-regulated targets in HCSC. The targets were enriched for several cancer cell stemness hallmarks and CSC pre-metastatic niche, which support these miRNAs role in suppression of HCSCs neoplastic transformation. Further, we constructed miRNA-Transcription factor (TF) regulatory networks, which provided new insights on the role of the proposed miRNA-TF co-regulation in the cancer stemness axis and its cross talk with the surrounding microenvironment. Our analysis revealed HCSC important hubs as candidate regulators for targeting hepatic cancer stemness such as, miR-148a, miR-214, E2F family, MYC and SLC7A5. Finally, we proposed a possible model for miRNA and TF co-regulation of HCSC signaling pathways. Our study identified an HCSC signature and set bridges between the reported results to give guide for future validation of HCC therapeutic strategies avoiding drug resistance.
机译:肝癌干细胞(HCSC)被认为是肝细胞癌(HCC)起始,转移,耐药性和复发的主要参与者。越来越多的证据支持HCSC中下调的miRNA作为干性状的关键抑制因子,但关于这些miRNA如何调节HCC发育的更多细节仍不清楚。为了揭示HCSC中的某些miRNA调控方面,我们在HCSC中编辑了15个下调的miRNA及其经过验证和预测的上调靶标。这些靶标丰富了几个癌细胞干性标记和CSC转移前的生态位,这些支持这些miRNA在抑制HCSC肿瘤转化中的作用。此外,我们构建了miRNA转录因子(TF)调控网络,这为拟议的miRNA-TF共同调控在癌症干轴中的作用及其与周围微环境的串扰提供了新见识。我们的分析显示,HCSC重要的中枢作为靶向肝癌干性的候选调控因子,例如miR-148a,miR-214,E2F家族,MYC和SLC7A5。最后,我们提出了HCSC信号通路的miRNA和TF共同调控的可能模型。我们的研究确定了HCSC签名,并在报告的结果之间架起了桥梁,为将来验证避免耐药性的HCC治疗策略提供指导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号